Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
- PMID: 11526226
- PMCID: PMC56908
- DOI: 10.1073/pnas.191379498
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo
Figures
Comment on
-
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- mice.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10320-5. doi: 10.1073/pnas.171060098. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504907 Free PMC article.
-
Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10314-9. doi: 10.1073/pnas.171076798. Epub 2001 Aug 14. Proc Natl Acad Sci U S A. 2001. PMID: 11504908 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
